Similarly, in neuroblastoma, inhibition of DHODH reprograms lipid metabolism through the mevalonate pathway, thereby promoting ferroptosis sensitivity and revealing a novel therapeutic vulnerability [15]. This evidence concerns the gene DHODH and neuroblastoma.